Delivering urokinase-type plasminogen activator using mulberry leaf exosomes enables thrombolysis and remodeling of venous microenvironments

Int J Biol Macromol. 2024 Dec;282(Pt 2):136866. doi: 10.1016/j.ijbiomac.2024.136866. Epub 2024 Oct 23.

Abstract

In the treatment of thrombosis, conventional nanocarriers inevitably have problems, such as adverse reactions and difficulties in synthesis. Inspired by the concept of 'medicine food homology,' we extracted and purified natural exosomes from mulberry leaves as carriers for the delivery of urokinase-type plasminogen activator (uPA) for targeted therapy. The obtained mulberry leaf exosomes (MLE) possessed a desirable hydrodynamic particle size (119.4 nm), a uniform size distribution (polydispersity index = 0.174), and a negative surface charge (-23.3 mv). Before loading with uPA, MLE were grafted with cyclic RGD (cRGD) to selectively bind activated platelets for thrombus targeting. The cytometry studies revealed that MLE@cRGD has a high thrombus targeting ability about 74.3 %. Animal tests demonstrated that the delivered uPA could dissolve clots almost completely in femoral vein thrombosis models. In addition, MLE could remodel venous microenvironments by effectively eliminating reactive oxygen species (ROS) and promoting the phenotypic transformation of macrophages from M1 to M2 for venous tissue repair.

Keywords: Macrophage; Mulberry leaf exosomes; Reactive oxygen species; Thrombolysis; Urokinase-type plasminogen activator.

MeSH terms

  • Animals
  • Drug Carriers / chemistry
  • Exosomes* / metabolism
  • Humans
  • Mice
  • Morus* / chemistry
  • Plant Leaves* / chemistry
  • Reactive Oxygen Species / metabolism
  • Thrombolytic Therapy / methods
  • Urokinase-Type Plasminogen Activator* / metabolism
  • Venous Thrombosis / drug therapy
  • Venous Thrombosis / metabolism

Substances

  • Urokinase-Type Plasminogen Activator
  • Drug Carriers
  • Reactive Oxygen Species